StreetInsider.com News Articles

Form 4 CRYO CELL INTERNATIONAL For: Nov 17 Filed by: PORTNOY DAVID

Wed, 19 Nov 2025 17:12:00 -0500

si-local-file:///var/storage/secattach/20251119/25639170.html

Form 4 CRYO CELL INTERNATIONAL For: Nov 17 Filed by: PORTNOY DAVID

Wed, 19 Nov 2025 17:12:00 -0500

si-local-file:///var/storage/secattach/20251119/25639170.html

Form 4 CRYO CELL INTERNATIONAL For: Nov 10 Filed by: PORTNOY DAVID

Wed, 12 Nov 2025 17:02:00 -0500

si-local-file:///var/storage/secattach/20251112/25599473.html

Form 4 CRYO CELL INTERNATIONAL For: Nov 10 Filed by: PORTNOY DAVID

Wed, 12 Nov 2025 17:02:00 -0500

si-local-file:///var/storage/secattach/20251112/25599473.html

Form 8-K CRYO CELL INTERNATIONAL For: Nov 12

Wed, 12 Nov 2025 17:01:00 -0500

si-local-file:///var/storage/secattach/20251112/25599440.html

Form 8-K CRYO CELL INTERNATIONAL For: Nov 12

Wed, 12 Nov 2025 17:01:00 -0500

si-local-file:///var/storage/secattach/20251112/25599440.html

Form 4 CRYO CELL INTERNATIONAL For: Oct 31 Filed by: PORTNOY DAVID

Tue, 04 Nov 2025 17:27:00 -0500

si-local-file:///var/storage/secattach/20251104/25555209.html

Form 4 CRYO CELL INTERNATIONAL For: Oct 31 Filed by: PORTNOY DAVID

Tue, 04 Nov 2025 17:27:00 -0500

si-local-file:///var/storage/secattach/20251104/25555209.html

Form 4 CRYO CELL INTERNATIONAL For: Oct 21 Filed by: Mizrahi Daniel

Thu, 23 Oct 2025 17:00:00 -0500

si-local-file:///var/storage/secattach/20251023/25495841.html

Form 4 CRYO CELL INTERNATIONAL For: Oct 21 Filed by: Mizrahi Daniel

Thu, 23 Oct 2025 17:00:00 -0500

si-local-file:///var/storage/secattach/20251023/25495841.html

Form 4 CRYO CELL INTERNATIONAL For: Oct 21 Filed by: Berger Harold D.

Thu, 23 Oct 2025 17:00:00 -0500

si-local-file:///var/storage/secattach/20251023/25495842.html

Form 4 CRYO CELL INTERNATIONAL For: Oct 21 Filed by: Berger Harold D.

Thu, 23 Oct 2025 17:00:00 -0500

si-local-file:///var/storage/secattach/20251023/25495842.html

Form 8-K CRYO CELL INTERNATIONAL For: Oct 18

Thu, 23 Oct 2025 17:00:00 -0500

si-local-file:///var/storage/secattach/20251023/25495853.html

Form 8-K CRYO CELL INTERNATIONAL For: Oct 18

Thu, 23 Oct 2025 17:00:00 -0500

si-local-file:///var/storage/secattach/20251023/25495853.html

Maxim Group Downgrades Cryo-Cell International, Inc. (CCEL) to Hold

Mon, 20 Oct 2025 07:59:02 -0500

Maxim Group analyst Allen Klee downgraded Cryo-Cell International, Inc. (NYSE: CCEL) from Buy to Hold.

For an analyst ratings summary and ratings history on Cryo-Cell International, Inc. click here. For more ratings news on Cryo-Cell International, Inc. click here.

Shares of Cryo-Cell International, Inc. closed at $4.55 yesterday.

Cryo-Cell International, Inc. (CCEL) Tops Q3 EPS by 13c

Thu, 16 Oct 2025 16:11:35 -0500

Cryo-Cell International, Inc. (NYSE: CCEL) reported Q3 EPS of $0.09, $0.13 better than the analyst estimate of ($0.04). Revenue for the quarter came in at $7.83 million versus the consensus estimate of $8.1 million.

For earnings history and earnings-related data on Cryo-Cell International, Inc. (CCEL) click here.

Form 10-Q CRYO CELL INTERNATIONAL For: Aug 31

Wed, 15 Oct 2025 17:01:00 -0500

si-local-file:///var/storage/secattach/20251015/25461442.html

Form 10-Q CRYO CELL INTERNATIONAL For: Aug 31

Wed, 15 Oct 2025 17:01:00 -0500

si-local-file:///var/storage/secattach/20251015/25461442.html

Cord Blood Banking Leader Cryo-Cell Reports Fiscal Third Quarter 2025 Financial Results

Wed, 15 Oct 2025 17:00:00 -0500

OLDSMAR, Fla.--(BUSINESS WIRE)-- Cryo-Cell International, Inc. (NYSE American LLC Symbol: CCEL) (the “Company”, “Cryo-Cell”), the world’s first private cord blood bank to separate and store stem cells in 1992, announced results for the fiscal third quarter ended August 31, 2025.

Financial Results

Revenue

Consolidated revenues for the third quarter of fiscal 2025 were $7.83 million compared to $8.07 million for the third quarter of fiscal 2024, a 3% decrease.

Net Income

The Company reported net income for the three months ended August 31, 2025 of $749,000, or $0.09 per basic share and diluted share, compared to net income of $1.05 million, or

Cord Blood Banking Leader Cryo-Cell Reports Fiscal Third Quarter 2025 Financial Results

Wed, 15 Oct 2025 17:00:00 -0500

Financial Results

Revenue

Consolidated revenues for the third quarter of fiscal 2025 were $7.83 million compared to $8.07 million for the third quarter of fiscal 2024, a 3% decrease.

Net Income

The Company reported net income for the three months ended August 31, 2025 of $749,000, or $0.09 per basic share and diluted share, compared to net income of $1.05 million, or

Cord Blood Banking Leader Cryo-Cell Reports Fiscal Third Quarter 2025 Financial Results

Wed, 15 Oct 2025 17:00:00 -0500

Financial Results

Revenue

Consolidated revenues for the third quarter of fiscal 2025 were $7.83 million compared to $8.07 million for the third quarter of fiscal 2024, a 3% decrease.

Net Income

The Company reported net income for the three months ended August 31, 2025 of $749,000, or $0.09 per basic share and diluted share, compared to net income of $1.05 million, or

Cord Blood Banking Leader Cryo-Cell Reports Fiscal Third Quarter 2025 Financial Results

Wed, 15 Oct 2025 17:00:00 -0500

Financial Results

Revenue

Consolidated revenues for the third quarter of fiscal 2025 were $7.83 million compared to $8.07 million for the third quarter of fiscal 2024, a 3% decrease.

Net Income

The Company reported net income for the three months ended August 31, 2025 of $749,000, or $0.09 per basic share and diluted share, compared to net income of $1.05 million, or

Cord Blood Banking Leader Cryo-Cell Reports Fiscal Third Quarter 2025 Financial Results

Wed, 15 Oct 2025 17:00:00 -0500

Financial Results

Revenue

Consolidated revenues for the third quarter of fiscal 2025 were $7.83 million compared to $8.07 million for the third quarter of fiscal 2024, a 3% decrease.

Net Income

The Company reported net income for the three months ended August 31, 2025 of $749,000, or $0.09 per basic share and diluted share, compared to net income of $1.05 million, or

Cord Blood Banking Leader Cryo-Cell Reports Fiscal Third Quarter 2025 Financial Results

Wed, 15 Oct 2025 17:00:00 -0500

Financial Results

Revenue

Consolidated revenues for the third quarter of fiscal 2025 were $7.83 million compared to $8.07 million for the third quarter of fiscal 2024, a 3% decrease.

Net Income

The Company reported net income for the three months ended August 31, 2025 of $749,000, or $0.09 per basic share and diluted share, compared to net income of $1.05 million, or

Cord Blood Banking Leader Cryo-Cell Reports Fiscal Third Quarter 2025 Financial Results

Wed, 15 Oct 2025 17:00:00 -0500

Financial Results

Revenue

Consolidated revenues for the third quarter of fiscal 2025 were $7.83 million compared to $8.07 million for the third quarter of fiscal 2024, a 3% decrease.

Net Income

The Company reported net income for the three months ended August 31, 2025 of $749,000, or $0.09 per basic share and diluted share, compared to net income of $1.05 million, or